Dexmedetomidine inhibits ferroptosis and attenuates sepsis-induced acute kidney injury via activating the Nrf2/SLC7A11/FSP1/CoQ10 pathway

Jiao Huang, Yang Zhao, Xi Luo, Yunpeng Luo, Jiemei Ji, Jia Li, Jian Lai, Ziru Liu, Yuanyuan Chen, Yunan Lin, Jingchen Liu · 2024

Read Dexmedetomidine inhibits ferroptosis and attenuates sepsis-induced acute kidney injury via activating the Nrf2/SLC7A11/FSP1/CoQ10 pathway by Jiao Huang, Yang Zhao, Xi Luo, Yunpeng Luo, Jiemei Ji, Jia Li, Jian Lai, Ziru Liu, Yuanyuan Chen, Yunan Lin, Jingchen Liu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11587839.txt.

Description

Jiao Huang and co-authors study a calming drug as a kidney shield in sepsis in this 2024 paper. Sepsis, a runaway infection response, often wounds the kidneys. An iron-driven cell death path helps drive that wound. The drug they test is known to calm patients in intensive care.

In mice and lab kidney cells, sepsis shut down a guard path that blocks the iron death route. The drug woke that path back up and eased tissue harm. Iron, rust marks, and cell damage fell, while guard stores rose. Blocking the path's head gene erased the drug's shield in both settings. The authors name the path as the drug's route of action.

Catalog record

CREATORJiao Huang, Yang Zhao, Xi Luo, Yunpeng Luo, Jiemei Ji, Jia Li, Jian Lai, Ziru Liu, Yuanyuan Chen, Yunan Lin, Jingchen Liu
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11587839

Browse the full library · About the Tower of Babel